SCHEMBL19619250

SCHEMBL19619250

NC1CC(N)C2OC3(CCCCC3)OC2C1OC1OC2COC3(CCCCC3)OC2C(O)C1N

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ LRAT O95237 2/20 0.36
▸ LMNA P02545 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.31
▸ TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19619212 0.90 LRAT (0.30) LRAT
SCHEMBL19944063 0.85 — —
SCHEMBL19944109 0.85 — —
SCHEMBL19944104 0.80 — —
SCHEMBL19619210 0.75 POLB (0.38) LRATLMNAKDM4EALOX15
SCHEMBL17323725 0.69 — —
SCHEMBL13890139 0.69 — —
SCHEMBL17323421 0.69 — —
SCHEMBL19619249 0.69 — —
SCHEMBL13873332 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007783-B1 NOVEL AMINOGLYCOSIDES AND USES THEREOF IN THE TREATMENT OF GENETIC DISORDERS TECHNION RES & DEV FOUNDATION (IL) 2018-07-11 — — EP disclosed
US-9821001-B2 Aminoglycosides and uses thereof in the treatment of genetic disorders TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) 2017-11-21 — — US disclosed
Send feedback